Dow Jones U.S. Pharmaceuticals Index


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Phibro Animal (S, US)  Pharmaceuticals
1. Phibro Animal (S, US)   Pharmaceuticals 90 84 35 95
2. Lannett (S, US)  Pharmaceuticals
2. Lannett (S, US)   Pharmaceuticals 51 60 36 70
3. Pfizer (XL, US)  Pharmaceuticals
3. Pfizer (XL, US)   Pharmaceuticals 47 8 40 8
4. Catalent (L, US)  Pharmaceuticals
4. Catalent (L, US)   Pharmaceuticals 38 100 21 80
5. Zoetis (XXL, US)  Pharmaceuticals
5. Zoetis (XXL, US)   Pharmaceuticals 36 90 29 80

October 27, 2017. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Catalent (L, US)   Pharmaceuticals
1. Catalent (L, US)   Pharmaceuticals 38 100 21 80
2. Supernus Pharma (S, US)   Pharmaceuticals
2. Supernus Pharma (S, US)   Pharmaceuticals 13 100 14 60
3. Zoetis (XXL, US)   Pharmaceuticals
3. Zoetis (XXL, US)   Pharmaceuticals 36 90 29 80
4. Pacira Pharma (S, US)   Pharmaceuticals
4. Pacira Pharma (S, US)   Pharmaceuticals 7 90 36 60
5. Phibro Animal (S, US)   Pharmaceuticals
5. Phibro Animal (S, US)   Pharmaceuticals 90 84 35 95
6. AbbVie (XXL, US)   Biotechnology
6. AbbVie (XXL, US)   Biotechnology 31 83 20 36
7. Prestige (M, US)   Pharmaceuticals
7. Prestige (M, US)   Pharmaceuticals 28 79 3 21
8. Eli Lilly (XL, US)   Pharmaceuticals
8. Eli Lilly (XL, US)   Pharmaceuticals 16 71 45 34
9. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
9. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 16 64 78 66
10. Lannett (S, US)   Pharmaceuticals
10. Lannett (S, US)   Pharmaceuticals 51 60 36 70

October 27, 2017. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 16 64 78 66
2. Nektar (S, US)   Pharmaceuticals
2. Nektar (S, US)   Pharmaceuticals 11 20 50 1
3. Merck (XL, US)   Pharmaceuticals
3. Merck (XL, US)   Pharmaceuticals 34 59 48 47
4. Eli Lilly (XL, US)   Pharmaceuticals
4. Eli Lilly (XL, US)   Pharmaceuticals 16 71 45 34
5. Pfizer (XL, US)   Pharmaceuticals
5. Pfizer (XL, US)   Pharmaceuticals 47 8 40 8

October 27, 2017. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Phibro Animal (S, US)   Pharmaceuticals
1. Phibro Animal (S, US)   Pharmaceuticals 90 84 35 95
2. Catalent (L, US)   Pharmaceuticals
2. Catalent (L, US)   Pharmaceuticals 38 100 21 80
3. Zoetis (XXL, US)   Pharmaceuticals
3. Zoetis (XXL, US)   Pharmaceuticals 36 90 29 80
4. Lannett (S, US)   Pharmaceuticals
4. Lannett (S, US)   Pharmaceuticals 51 60 36 70
5. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
5. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 16 64 78 66
6. Pacira Pharma (S, US)   Pharmaceuticals
6. Pacira Pharma (S, US)   Pharmaceuticals 7 90 36 60
7. Supernus Pharma (S, US)   Pharmaceuticals
7. Supernus Pharma (S, US)   Pharmaceuticals 13 100 14 60
8. Akorn (M, US)   Pharmaceuticals
8. Akorn (M, US)   Pharmaceuticals 33 60 29 60

October 27, 2017. Top 10s are published weekly by . ()

This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer then 10 stocks due to Obermatt’s top 10 quality standards

.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from October 27, 2017.

Top 10 Stock History D.J. US Pharmaceutical